Laboratory measurements quantifying the fraction of total circulating testosterone that is unbound to Sex Hormone-Binding Globulin (SHBG) or albumin, thus capable of exerting androgenic effects at the cellular level. Assessing these metrics provides a more accurate representation of androgenic status than measuring total testosterone alone. Clinical interpretation requires understanding the dynamic interplay with SHBG concentration.
Origin
This metric originates from the need to refine assessment beyond total circulating hormones, focusing specifically on the physiologically active fraction relevant to clinical endpoints like muscle mass or libido. It reflects the functional endocrine state rather than mere production volume.
Mechanism
Testosterone circulates bound to SHBG (high affinity) or weakly bound to albumin (low affinity). The unbound fraction, often calculated using validated formulae like the Vermeulen calculation, represents the free and weakly bound components that can readily diffuse into target cells. Optimization involves ensuring adequate SHBG binding capacity while maximizing the free fraction within a healthy reference range.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.